KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Long-Term Deferred Tax (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 6.35% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, down 6.35% year-over-year, with the annual reading at $1.8 billion for FY2025, 6.35% down from the prior year.
  • Long-Term Deferred Tax hit $1.8 billion in Q4 2025 for Bausch Health Companies, down from $2.1 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $2.4 billion in Q3 2022 to a low of $1.8 billion in Q4 2025.
  • Historically, Long-Term Deferred Tax has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2022.
  • Biggest five-year swings in Long-Term Deferred Tax: rose 23.56% in 2021 and later decreased 8.0% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $2.3 billion in 2021, then decreased by 3.82% to $2.2 billion in 2022, then fell by 3.0% to $2.1 billion in 2023, then decreased by 6.33% to $2.0 billion in 2024, then fell by 6.35% to $1.8 billion in 2025.
  • Business Quant data shows Long-Term Deferred Tax for BHC at $1.8 billion in Q4 2025, $2.1 billion in Q3 2025, and $2.0 billion in Q2 2025.